Skip to main content
Clinical Trials/NCT01953380
NCT01953380CompletedNot Applicable

Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy

Region Skane1 site in 1 country400 target enrollmentStarted: October 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
400
Locations
1
Primary Endpoint
knowledge

Study Overview

Brief Summary

The purpose of this study is to determine whether extended information given to patients with contact allergy improves knowledge, treatment efficacy and daily functioning.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients with suspected contact allergy
  • •Age above 18 years
  • •Participants have given informed consent

Exclusion Criteria

  • •Mental or language disabilities

Arms & Interventions

extended information

Active Comparator

Extended information on specific allergy

Intervention: extended information (Behavioral)

Information according to clin. routine

No Intervention

Information according to clinical routine

Outcomes

Primary Outcomes

knowledge

Time Frame: one year after inclusion

knowledge about specific contact allergies and exposure, assessed by questionnaire, a modified version of Nordic Occupational Skin Questionnaire NOSQ-2002/Long, and patient records.

Secondary Outcomes

  • clinical improvement(one year after inclusion)
  • quality of life(one year after inclusion)
  • effect on daily functioning(one year after inclusion)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Andreas Sonesson

MD PhD

Region Skane

Study Sites (1)

Loading locations...

Similar Trials